HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 283, Issue 33, 22867-22874, August 15, 2008

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 283/33/22867    most recent M801320200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Google Scholar Articles by Yao, X. Articles by Xu, L. PubMed PubMed Citation Articles by Yao, X. Articles by Xu, L. Social Bookmarking                      What's this?

Preferential Utilization of Imp7/8 in Nuclear Import of Smads^*

From the Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605

Trafficking of Smad proteins between the cytoplasm and nucleus is a critical component of transforming growth factor β (TGF-β) signal transduction. Smad4 translocates into the nucleus either in response to TGF-β stimulation or when its nuclear export is blocked by leptomycin B (LMB). We demonstrate that both TGF-β-induced and basal state spontaneous nuclear import of Smad4 require importin 7 and 8 (Imp7,8). Our data suggest that in the nuclear import of Smad4, the role of Imp8 is irreplaceable by Imp7, and that Smads preferentially bind Imp8. Interestingly, in contrast to its mammalian counterpart Smad4, Drosophila Medea appears to utilize different mechanisms for TGF-β-induced or basal state nuclear accumulation, with the latter independent of Msk (Drosophila Imp7/8) function. In addition, overexpression of Imp8 alone was sufficient to cause an increased concentration of Smad1, 3 and 4 in the nucleus, but had very limited effects on Smad2. These observations suggest selective involvement of Imp8/Msk in nuclear import of different Smads under different conditions.

Received for publication, February 19, 2008 , and in revised form, May 30, 2008.

^* This work was supported, in whole or in part, by National Institutes of Health Grant R01CA108509. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. S1 and Tables S1-S5.

¹ To whom correspondence should be addressed: Program in Molecular Medicine, University of Massachusetts Medical School, 373 Plantation St., Rm. 308, Worcester, MA 01605. Tel.: 508-856-4273; Fax: 508-856-6662; E-mail: lan.xu{at}umassmed.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				W. O. Miles, E. Jaffray, S. G. Campbell, S. Takeda, L. J. Bayston, S. P. Basu, M. Li, L. A. Raftery, M. P. Ashe, R. T. Hay, et al. Medea SUMOylation restricts the signaling range of the Dpp morphogen in the Drosophila embryo Genes & Dev., September 15, 2008; 22(18): 2578 - 2590. [Abstract] [Full Text] [PDF]